Board of Directors

Ric is Executive Chairman of the group and a licensed insolvency practitioner, having qualified as a chartered accountant with Arthur Andersen. He established Traynor & Co. in 1989 which, following the acquisition of Begbies London in 1997, became Begbies Traynor. He led the group’s successful introduction to AIM in 2004.

Ric focusses on the strategic development of the group and supporting the management board in developing and executing our growth strategy. He remains a major shareholder in the group.

Mark is Chief Executive Officer (CEO) and a licensed insolvency practitioner. He joined the group in 2005 following the acquisition of his practice, and was initially appointed to the board in 2011, as head of restructuring and advisory, before being appointed as CEO in September 2025.

Mark is responsible for the day-to-day leadership of the group, driving the ongoing implementation of our growth strategy, with responsibility for overall business performance. He continues to act as a senior fee earning partner and has been appointed on numerous complex and high-profile assignments. He is a former president of the Insolvency Practitioners Association.

Nick is Chief Financial Officer (CFO) and a member of the group’s management board. Nick joined the group in 2007 and was appointed to the board in 2010.

Nick is responsible for the group’s financial strategy, management and reporting and has executive oversight for IT and people strategy. Nick qualified as a chartered accountant with KPMG and previously held senior finance roles in United Utilities PLC and Vertex Data Science Limited, the business process outsourcer.

John was appointed to the board in 2007 as a non-executive director. He was previously an executive director of Caledonia Investments plc from 2003-2011 prior to which he worked for the Hambros Group for over 20 years, where he was an executive director of Hambros Bank and joint managing director of Hambro Countrywide. John also has extensive non-executive experience having been a director of more than 40 listed and private companies operating.

Mark was appointed to the board in 2017 as a non-executive director. He has significant property services experience as a result of his senior roles in major firms, including King Sturge as UK managing partner, when he negotiated the sale of the business to JLL. Following the acquisition, Mark was appointed as JLL’s UK chief operating officer until leaving the business in December 2016. During this time, he completed a number of UK acquisitions. Mark now runs his own consultancy business focussing on strategy and change in professional services businesses, and is the chairman of Jones Lang LaSalle Pension Trustees Limited.

Peter was appointed to the board in December 2019 as a non-executive director.

Peter has spent his career in information technology. In 2010, he co-founded and became chief executive officer at the AI company RAVN Systems which delivered digital transformation initiatives in the professional services industry. RAVN Systems was acquired by iManage, a leading vendor of document management systems for the legal and professional services industries in 2017 and following the acquisition, Peter served as VP of Strategy and Global Practice Director for iManage, until he left the business in October 2019.

Mandy was appointed to the board in February 2023 as a non-executive director. Mandy is a chartered accountant and experienced non-executive director. She joined EY in 1992 and spent 10 years working in professional roles in the firm. In 2002 she was appointed as EY's UK director of finance and operations and from 2007-2012 was the global director of finance and operations for EY's transaction advisory services and EY assurance services. Since 2012, Mandy has held a number of non-executive director positions in the financial and professional services sectors including at Punter Southall Group, Liontrust Asset Management plc, JP Morgan Investment Trust plc and Gowling WLG LLP, as well as in the not for profit sector at the Institute of Cancer Research; these roles included acting as chair of several audit committee and risk committees.